LATEST
Medigene, bluebird bio Expand Immunotherapy Pact
By
Medigene, a Martinsried, Germany-based biotechnology company focused on personalized T-cell-based immunotherapies, has expanded its strategic alliance with bluebird bio, a Cambridge, Massachusetts-based clinical-stage gene therapy company, for research and development…
Amneal, Impax Close Merger; To Close California Manufacturing Facilities
By
Amneal Pharmaceuticals, a Bridgewater, New Jersey generic-drug manufacturer and Impax Laboratories, a Hayward, California-based specialty pharmaceutical company, have closed on their previously announced business combination. Following the close of the…
Aurobindo Recalls 1.5 Million Bags For Issues of Sterility Assurance
By
Auromedics Pharma, a Princeton, New Jersey-based subsidiary of Aurobindo Pharma, a Hyderabad, India-headquartered generics and active pharmaceutical ingredients manufacturer, has voluntarily initiated a recall in the US of 1.5 million…
Aspen Pharma Opens $80-Million High-Potency Manufacturing Facility
By
Aspen Pharmacare, a KwaZulu-Natal, South Africa-headquartered pharmaceutical company, has opened a 1-billion rand ($80-million) high-containment drug-product manufacturing facility in Port Elizabeth, South Africa. The 23,000-square-meter facility has been audited by…
UK CAR-T Therapy Startup Autolus Files for $100 Million IPO
By
Autolus Therapeutics, a London-headquartered clinical-stage biopharmaceutical company developing chimeric antigen receptor T cell (CAR-T) therapies with a semi-automated manufacturing process, has filed a registration statement with the US Securities and…
